Download Sample
Schedule a Meeting
NA : +1 804 441 9344
sales@towardshealthcare.com
August 2025
The global oxygen concentrators market size is estimated at US$ 1.14 billion in 2024, is projected to grow to US$ 1.21 billion in 2025, and is expected to reach around US$ 2.05 billion by 2034. The market is projected to expand at a CAGR of 6.06% between 2025 and 2034.
The oxygen concentrators market is expanding rapidly due to increasing cases of chronic respiratory diseases. A growing aging population, increasing prevalence of smoking-associated disorders. North America is dominated by growing technological advancements like energy-efficient and portable models, improving patient convenience and adoption. Asia Pacific is the fastest growing as the presence of an advanced healthcare system and improving medical access.
| Table | Scope |
| Market Size in 2025 | USD 1.21 Billion |
| Projected Market Size in 2034 | USD 2.05 Billion |
| CAGR (2025 - 2034) | 6.06% |
| Leading Region | North America |
| Market Segmentation | By Device Type, By Technology / Flow Mechanism, By Application / End-Use Settings, By End-User, By Region |
| Top Key Players | Philips Healthcare (Philips Respironics), Invacare Corporation, Inogen Inc., Drive DeVilbiss Healthcare (DeVilbiss), Caire Inc. (Chart Industries), O2 Concepts, Nidek Medical Products, GCE Group, Precision Medical Inc., Teijin Limited, Belluscura, React Health, Lincare Holdings (Linde subsidiary), Air Liquide Healthcare, Drägerwerk AG (Dräger), Ventec Life Systems, GCE Healthcare |
The oxygen concentrators market comprises medical devices that extract oxygen from ambient air to deliver therapeutic oxygen to patients with respiratory insufficiencies. These devices include portable, fixed (stationary), continuous flow, and pulse flow systems used across home-healthcare, hospitals, and mobile care settings. The market is driven by increasing chronic respiratory diseases (e.g., COPD, asthma), an aging global population, rising demand for home healthcare, and technological innovations improving portability, usability, and monitoring.
For instance,
For Instance,
Integration of AI in oxygen concentrators drives the growth of the market, as AI has significant potential to advance mechanical oxygen concentrators for severely ill patients. By consistently monitoring patient information, with respiratory patterns, lung mechanics, and blood gas levels, AI-driven technology adjusts oxygen concentrator parameters in real time, confirming optimal support for the patient's respiratory system. This enhances patient comfort, reduces challenges, and potentially limits the duration of mechanical ventilation. AI-based algorithms are established to examine patient data and endorse personalized oxygen therapy adjustments, improving treatment and potentially lowering hospital readmissions. Real-time feedback, identification of potential challenges with the oxygen concentrator, reminders for apparatus refills, and maintenance alerts are some ways AI technology is predicted to improve patient care in the future.
Increasing Applications of Oxygen Concentrators
Oxygen concentrators significantly enhance the quality of life for people with respiratory issues by augmenting oxygen supply. These devices are vital for individuals facing challenges with their respiratory care, whether due to acute conditions, chronic diseases, or recovery after surgery. Their main function is to deliver concentrated oxygen to those with low blood oxygen levels, ensuring they receive the oxygen necessary for proper biological function. Unlike standard oxygen tanks, oxygen concentrators draw in ambient air, remove nitrogen, and provide pure oxygen. This simple, reliable method of supporting breathing has contributed to the expanding market for oxygen concentrators.
Major Challenges in Using Oxygen Concentrators
If an oxygen concentrator frequently shuts off, it might be caused by electrical problems, overheating, or internal faults. Recognizing common issues like this can assist in quick troubleshooting. When the device doesn’t deliver the proper oxygen levels, it could be due to clogged filters, failing sieve beds, or a less efficient compressor, which in turn affects the growth of the oxygen concentrators market.
Innovations in Wearable Concentrator Technology
Innovations in concentrator technology include the development of wearable oxygen concentrators, which can be worn like a backpack and provide a steady oxygen flow. This makes it easier for patients to stay active and mobile. Additionally, smart oxygen concentrators utilize advanced sensors and algorithms to monitor breathing and automatically adjust oxygen delivery. These advancements help patients maintain their health and ensure they receive the proper oxygen levels. Such improvements simplify managing oxygen therapy and enable timely adjustments, contributing to the growth of the oxygen concentrator market.
For Instance,
By device type, the fixed/stationary oxygen concentrators segment led the oxygen concentrators market, due to stationary oxygen concentrators are generally used by patients on LTOT, as they are affordable and safer than using compressed gas cylinders. Oxygen concentrators are recommended for patients using oxygen for >1.4 h·day. Stationary concentrators offer an uninterrupted oxygen supply with a flow ranging from 0.5 to 10–15 L·min. Stationary oxygen concentrators offer a convenient refill supply in a car or van throughout long trips from home.
On the other hand, the portable oxygen concentrators segment is projected to experience the fastest CAGR from 2025 to 2034, as the increasing demand for mobile health technologies, as mobility is significant for the elderly, and portable oxygen concentrators confirm that those who need oxygen therapy lead active, fulfilling lives. The incorporation of digital health technologies is a noteworthy trend, offering peace of mind for patients and caregivers. These advancements in portable oxygen concentrators provide greater freedom, independence, and mobility for end-users. It supports transforming the way to manage respiratory diseases. Portable oxygen concentrators have come a long way in recent years, significantly improving the lives of those who require oxygen therapy.
By technology, the continuous flow segment is dominant in the oxygen concentrators market in 2024, as these concentrators are often chosen by medical care providers for their capability to deliver oxygen reliably. It is well-matched with nearly every patient, particularly those with serious respiratory situations or momentous breathing problems. Patients on long-term oxygen therapy (LTOT) may need an incessant flow machine while they sleep to prevent overnight oxygen desaturation. The continuous flow delivery process is the only appropriate option to ensure adequate oxygen levels throughout the night.
The pulse flow segment is projected to grow at the fastest CAGR from 2025 to 2034, as these concentrators are extremely efficient in respiratory diseases. By carrying oxygen only when the end user inhales, these strategies lessen oxygen wastage compared to continuous flow systems. This conversation not only extends the battery life of the concentrator but also confirms that the end-user receives the oxygen precisely when required. This targeted delivery process is predominantly beneficial for those with fluctuating oxygen needs throughout the day.
By application, the home care segment led the oxygen concentrators market in 2024, as these concentrators help get the oxygen needed if patients have conditions such as COPD, bronchitis, or heart disease. Their size enables them to fit in comparatively less space. Therefore, easy to carry and get access the oxygen without any challenges. Home oxygen concentrators provide an infinite supply of oxygen, but they need to be plugged into an electrical outlet at all times, meaning they’re not model for someone who wants to navigate their home care more simply.
The non-home care segment is projected to experience a lucrative CAGR from 2025 to 2034, as it provides major benefits for mental and physical health by providing optimum oxygenation, which enhances cognitive performance and emotional stability. People contemplating oxygen treatment should pursue personalized guidance from healthcare authorities and investigate the advantages of oxygen concentrators in endorsing respiratory well-being. They are harmless and more convenient than tanks or cylinders, and they remove the expense and diverse expenses related to purchasing oxygen.
By end-user, the home users/patients segment led the oxygen concentrators market in 2024, as oxygen concentrators are intended to blend impeccably into the home environment. They do not take up much space, and major models are artistically fair. Their patient-friendly design ensures that patients can use them without extensive technical knowledge. Whether used incessantly throughout sleep or intermittently through the day, their flexibility makes them standard for housing settings.
On the other hand, the hospitals & healthcare facilities segment is projected to experience the fastest CAGR from 2025 to 2034, as oxygen is a vital medicine applied to care for patients at all levels of the healthcare system, including in trauma, surgery, asthma, heart failure, pneumonia, and maternal and child care. These campaigns support reducing shortness of breath, raising energy levels, and enhancing sleep quality.
North America is dominant in the market in 2024, as increasing applications of oxygen concentrators, with more than 1.5 million North Americans utilizing an oxygen concentrator for supplemental oxygen therapy. Enhanced public and policymakers’ awareness that respiratory health is significant to worldwide health and that childhood respiratory disease has long-term negative consequences on adult health. More than 35 million people living in the U.S. live with a chronic lung disease such as asthma and COPD. The North American Lung Association is the leading organization working to save lives by enhancing lung health and avoiding lung disease through research and advanced technology, which contributes to the growth of the market.
For Instance,
In the U.S., the aging population 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050. Six out of ten U.S. adults have at least one chronic disease. These chronic diseases include heart disease, asthma, high blood pressure, and diabetes, which increase the demand for oxygen concentrators. The growing adoption of portable oxygen concentrator manufacturing is observing huge growth in the emerging economies due to increasing disposable income and increasing incidences of chronic diseases, which contribute to the growth of the market.
Growing utilization of oxygen concentrator units, the increasing total load demand in Canada. Rising government funding and medical awareness for respiratory care increase the demand for oxygen concentrators.
Asia Pacific is the fastest-growing region in the oxygen concentrators market in the forecast period, as oxygen concentrator-based solutions help to the increasing of oxygen to small health facilities in Asia Pacific. The growing burden of chronic diseases, the necessity to manage chronic conditions, are some factors that triggered the requirement for, and operation of, combined care models in the Asia Pacific region, which drives the growth of the market.
China is shifting to increase the supply of medical oxygen generators in formerly poor counties, which have been lifted out of poverty. China’s medical sector is experiencing huge growth, driven by growing incomes, rising health awareness, and an aging population. China’s healthcare sector is the largest and fastest-growing sector in the Asia Pacific, which drives the growth of the market.
In India, increasing digital healthcare infrastructure is evolving to bridge the gap between urban and rural medical services, leveraging e-commerce, electronic health records (EHRs), and artificial intelligence (AI)-based diagnostics. India's medical infrastructure is varied and involves a broad range of services, from primary healthcare centres to tertiary care hospitals, which contribute to the growth of the market.
Europe is notably growing in the oxygen concentrators market, as increasing partnerships and collaborations with healthcare institutions as Citius Healthcare Consulting, partnered with a medical technology company to enable their expansion to Europe by making their portable oxygen concentrator (POC) a connected device compliant with GDPR privacy guidelines, which drives the growth of the market.
In Germany, increasing funding to the healthcare system through the public sector in the form of social insurance payments specifically covers the costs of state supervision and basic healthcare infrastructure, which is driving the growth of the market.
In the UK, growing awareness of chronic disease and early adoption of advanced healthcare technology. Increasing local manufacturing due to lower costs and improving raw material availability, which increases the demand for oxygen concentrators. Increasing cases of respiratory diseases due to smoking, industrial exposure and smoking contribute to the growth of the market.
In June 2025, Kevin Smith, President and Chief Executive Officer, stated, “With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients. This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy.”
By Device Type
By Technology / Flow Mechanism
By Application / End-Use Settings
By End-User
By Region
August 2025
August 2025
August 2025
August 2025